Reverse logistics management, critical to clinical trials.
Good planning is paramount in the execution of Clinical Trials and so are the reverse logistics. Effective clinical trial reverse logistics are vital to ensure the smooth progression of the trial, equipment is maintained and environmental waste is minimised. Read more to understand the planning considerations necessary or contact BS3 to discuss your reverse logistics needs further.
MDMA & Psilocybin to be rescheduled from S9 to S8
3rd February 2023, the Therapeutic Goods Administration (TGA) announced that from the 1st July 2023, medical use of MDMA and Psilocybin will be rescheduled from Schedule 9 (prohibited substances) to Schedule 8 (controlled medicines) of the Poisons Standard. Which will enable authorised psychiatrists to prescribe these substances for treatment-resistant depression and treatment resistant post-traumatic stress disorder.
Medical cannabis prescriptions surge in Australia
The first in depth study of Australia's medicinal cannabis program shows huge prescription growth over the last 2 years in Australia as more doctors begin to prescribe it for pain relief and management of chronic illness. More than 248,000 prescriptions have been approved over the past five years with 85% of that figure given out post January 2020.
